Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Thoracic Cancer|December 1, 2021
Clinical outcome, long-term survival and tolerability of sequential therapy of first-line crizotinib followed by alectinib in advanced ALK+NSCLC: A multicenter retrospective analysis in ChinaZihua Zou, Xuezhi Hao, Cuiying Zhang, et al.
Translational Lung Cancer Research|May 19, 2025
Effect of the number of induction chemotherapy cycles on the efficacy of first-line atezolizumab combined with chemotherapy in extensive-stage small cell lung cancerMengxing You, Jiayu Liu, Fei Teng, et al.
Lung Cancer (Amsterdam, Netherlands)|February 15, 2024
Longitudinal plasma proteomic profiling of EML4-ALK positive lung cancer receiving ALK-TKIs therapyShasha Wang, Xuezhi Hao, Liyuan Dai, et al.
Frontiers in Oncology|April 17, 2023
Effectiveness of neoadjuvant immunochemotherapy compared to neoadjuvant chemotherapy in non-small cell lung cancer patients: Real-world data of a retrospective, dual-center studyKailun Fei, Gang Guo, Jie Wang, et al.
Cancer Medicine|March 20, 2016
A prognostic model for platinum-doublet as second-line chemotherapy in advanced non-small-cell lung cancer patientsHongnan Mo, Xuezhi Hao, Yutao Liu, et al.
BMC Medicine|August 28, 2022
Pyrotinib combined with apatinib for targeting metastatic non-small cell lung cancer with HER2 alterations: a prospective, open-label, single-arm phase 2 study (PATHER2)Guangjian Yang, Haiyan Xu, Yaning Yang, et al.
Cancer Immunology, Immunotherapy : CII|May 24, 2025
Clinical, immune cell, and genetic features predicting survival and long-term response to first-line chemo-immunotherapy treatment for non-small cell lung cancerLiling Huang, Haohua Zhu, Liyuan Dai, et al.
Molecular Cancer Research : MCR|December 19, 2022
Evolutionary Characteristics and Immunologic Divergence of Lung and Brain Metastasis Lesions in NSCLCTongji Xie, Zhenghao Liu, Yan Li, et al.
Cancer Research Communications|April 7, 2023
Detection of MET Polysomy by Next-generation Sequencing and Its Clinical Relevance for MET InhibitorsBoyang Sun, Tian Qiu, Xiaoling Zeng, et al.
Journal of Cellular and Molecular Medicine|August 9, 2019
Co-mutational assessment of circulating tumour DNA (ctDNA) during osimertinib treatment for T790M mutant lung cancerPuyuan Xing, Xiaohong Han, Sha Wang, et al.
Pageof 11